Alpha 2.0
Login Register
» Articles » PMID: 35100728

Potentially Curative Targeted Therapy for Undifferentiated High-Grade Sarcoma Developing After Malignant Transformation of a V600E-Mutated Ameloblastic Fibroma

Overview
Journal JCO Precis Oncol
Specialty Oncology
Date 2022 Feb 1
PMID 35100728
Authors
Nikolay Zhukov
Yulia Mareeva
Dmitry Konovalov
Alexander Druy
Nikolay Grachev
Dmitry Litvinov
Affiliations
Soon will be listed here.
Citing Articles

Rapid but nondurable response of a exon 15 double-mutated spindle cell sarcoma to a combination of BRAF and MEK inhibitors.

Sinichenkova K, Sidorov I, Kriventsova N, Konovalov D, Abasov R, Usman N Oncotarget. 2024; 15:493-500.

PMID: 39018206 PMC: 11254299. DOI: 10.18632/oncotarget.28606.

Anti-MAPK Targeted Therapy for Ameloblastoma: Case Report with a Systematic Review.

Raemy A, May L, Sala N, Diezi M, Beck-Popovic M, Broome M Cancers (Basel). 2024; 16(12).

PMID: 38927880 PMC: 11201667. DOI: 10.3390/cancers16122174.

Malignant Odontogenic Tumours: A Systematic Review of Cases Reported in Literature.

Marin C, Dave M, Hunter K Front Oral Health. 2022; 2:775707.

PMID: 35048074 PMC: 8757763. DOI: 10.3389/froh.2021.775707.

Comparative Analysis Between Dentinogenic Ghost Cell Tumor and Ghost Cell Odontogenic Carcinoma: A Systematic Review.

Vieira G, de Pinho Montovani P, Rozza-de-Menezes R, Cunha K, Conde D Head Neck Pathol. 2021; 15(4):1265-1283.

PMID: 34128137 PMC: 8633206. DOI: 10.1007/s12105-021-01347-z.